Cardinal Health, Inc. CAH NYSE

Cardinal Health, Inc. (CAH) reported strong year-over-year revenue growth of +10% through 2025-12 (TTM revenue vs prior-year TTM). Net income showed exceptional earnings expansion of +27.2% YoY, reaching $471M in the latest quarter. The net profit margin is 0.7%, which is thin. The company has maintained profitability in all 4 quarters. The gross margin is 3.7% (low), up 0.3pp vs the prior year. With a $51B market cap, MOAT composite score of 49/100 (moderate competitive position).

Criteria proven by this page:

• GROWTH (83/100, Pass) — proving strong growth momentum
• PAST (75/100, Pass) — proving consistent earnings. Looking at the full 40-year annual history, the company was profitable in 38 of 40 years — an excellent long-term track record
• INCOME (30/100, Partial) — the company is profitable but margin is below 15%
• MOAT (49/100, Partial) — some competitive advantages are present but not dominant

Overall SharesGrow Score: 56/100 with 1/7 criteria passed.